Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04927741 · ClinicalTrials.gov registry record · NA

Essential Oils Following IUD Insertion

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT04927741: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT04927741 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04927741, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This study will measure the effects of topical application of sweet marjoram essential oil + grapeseed oil with massage on uterine cramping/pain post-IUD insertion/placement. The intention is to conduct a pilot study that could give a first look at the data to determine whether this line of research is worth pursuing with more time, effort, and resources. The results of this pilot study will provide adequate data (e.g., variance estimates) needed for obtaining reasonably reliable sample size estimates if larger studies are warranted in the future.

Primary Outcome

Pain/discomfort rating change following topical application of sweet marjoram + grapeseed oil with massage after IUD insertion. (Pain/discomfort assessed by NRS on scale of 0-10).

Interventions

  • OTHER Sweet Marjoram Essential Oil
  • OTHER Grapeseed Oil

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-05-27
Est. Completion 2022-05-26
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT04927741 record still lists

NCT04927741 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Sweet Marjoram Essential Oil is the first listed.

NCT04927741 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04927741 about?

NCT04927741 is a clinical study titled "Essential Oils Following IUD Insertion". This study will measure the effects of topical application of sweet marjoram essential oil + grapeseed oil with massage on uterine cramping/pain post-IUD insertion/placement. The intention is to conduct a pilot study that could give a first look at the data to determine whether this line of researc...

What is the current status of trial NCT04927741?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-05-27. Estimated completion is 2022-05-26.

What interventions are being tested in trial NCT04927741?

The interventions under investigation include: Sweet Marjoram Essential Oil (OTHER), Grapeseed Oil (OTHER).

Who is sponsoring clinical trial NCT04927741?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04927741's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04927741, the US trial registry maintained by the National Library of Medicine. NCT04927741 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.